Boulevard Bio is a precision immunology company built to change the course of B cell–driven autoimmune diseases.

Incubated by Deerfield Management, Boulevard Bio was founded by pioneers in B cell biology and is led by veteran biotech executives with proven track records of successfully developing and commercializing therapies across modalities and indications.